
Tyra Biosciences Inc (TYRA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1539.773 | -112.897 | -16.296 | -19.315 | -28.101 |
Return on Equity (%) | 171.483 | 101.594 | -18.253 | -19.774 | -29.922 |
Return on Invested Capital (%) | 128.53 | -209.133 | -16.694 | -21.286 | -35.475 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -4.55 | 19.905 | 7.281 | 6.087 | 4.744 |
Earnings Per Share | -3.901 | -13.261 | -0.634 | -1.306 | -1.606 |
Cash Per Share | 0.104 | 21.625 | 7.292 | 5.931 | 1.347 |
Working Capital Per Share | -4.825 | 19.067 | 7.25 | 5.94 | 4.56 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -3.901 | -13.261 | -0.634 | -1.306 | -1.606 |
EBITDA Per Share | -3.901 | -13.261 | -0.634 | -1.306 | -1.606 |
Free Cash Flow Per Share | -3.89 | -12.885 | -0.622 | -1.3 | -1.596 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,04M | 704k | 41,44M | 42,35M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 42,35M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 647,21M |
Ratio cours/bénéfice | -9,3 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 11,09 |
Ratio prix/valeur comptable | 3,15 |
Rendement de dividende | - |
Actions en circulation | 50,6M |
Volume moyen (1 semaine) | 242,51k |
Volume moyen (1 mois) | 263,18k |
Variation sur 52 semaines | -33,10% |
Plus haut sur 52 semaines | 29,60 |
Plus bas sur 52 semaines | 11,88 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales